Compounds > 2,6-diaminopurine 2',3'-dideoxyriboside
Page last updated: 2024-08-24

2,6-diaminopurine 2',3'-dideoxyriboside and HIV

2,6-diaminopurine 2',3'-dideoxyriboside has been researched along with HIV in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, J; De Clercq, E; Naesens, L; Robins, MJ1
Baba, M; Balzarini, J; de Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Wood, SG1
Baba, M; Balzarini, J; De Clercq, E; Desmyter, J; Herdewijn, P; Madej, D; Pauwels, R; Robins, MJ; Zou, RM1
Baba, M; Balzarini, J; De Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Zou, RM1
Balzarini, J; De Clercq, E; Herdewijn, P; Robins, MJ; Zou, RM1

Other Studies

5 other study(ies) available for 2,6-diaminopurine 2',3'-dideoxyriboside and HIV

ArticleYear
Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside.
    Journal of acquired immune deficiency syndromes, 1990, Volume: 3, Issue:12

    Topics: Animals; Antiviral Agents; Cell Line; Cell Transformation, Viral; Cytopathogenic Effect, Viral; Didanosine; Dideoxyadenosine; Drug Synergism; Fibroblasts; HIV; Humans; Mice; Mice, Inbred Strains; Moloney murine sarcoma virus; Ribavirin; Sarcoma, Experimental; Virus Replication

1990
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    Molecular pharmacology, 1988, Volume: 33, Issue:3

    Topics: Adenosine Deaminase; Antimetabolites; Antiviral Agents; Coformycin; Deoxyadenosines; Deoxyguanosine; Dideoxyadenosine; Dideoxynucleosides; HIV; Pentostatin; Prodrugs; Solubility; Virus Replication

1988
Investigations on the anti-HIV activity of 2',3'-dideoxyadenosine analogues with modifications in either the pentose or purine moiety. Potent and selective anti-HIV activity of 2,6-diaminopurine 2',3'-dideoxyriboside.
    Biochemical pharmacology, 1988, Apr-01, Volume: 37, Issue:7

    Topics: Adenosine Deaminase; Animals; Antiviral Agents; Cell Line; Deamination; Deoxyadenosines; Dideoxyadenosine; HIV; Humans; Mice; Moloney murine sarcoma virus; Structure-Activity Relationship; Tumor Cells, Cultured

1988
The 2',3'-dideoxyriboside of 2,6-diaminopurine selectively inhibits human immunodeficiency virus (HIV) replication in vitro.
    Biochemical and biophysical research communications, 1987, May-29, Volume: 145, Issue:1

    Topics: Adenosine Deaminase Inhibitors; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Cell Transformation, Viral; Deoxyadenosines; Dideoxyadenosine; DNA Replication; HIV; HIV Antigens; Humans; Virus Replication

1987
The 2',3'-dideoxyriboside of 2,6-diaminopurine and its 2',3'-didehydro derivative inhibit the deamination of 2',3'-dideoxyadenosine, an inhibitor of human immunodeficiency virus (HIV) replication.
    Biochemical and biophysical research communications, 1987, May-29, Volume: 145, Issue:1

    Topics: Adenosine Deaminase; Animals; Cattle; Deoxyadenosines; Dideoxyadenosine; Dideoxynucleosides; DNA Replication; HIV; Intestines; Kinetics; Nucleoside Deaminases; Substrate Specificity; Virus Replication

1987